These findings suggest that measuring plasma CGRP can serve as an early predictive indicator of the effectiveness of amlodipine in pediatric primary hypertension, which may also be suitable for the guidance of antihypertensive treatment in children with secondary hypertension. The gene discussed is CALCA; the disease is secondary hypertension.